Established in 2022 between ISCT Asia Regional Executive Committee and ISCT Industry Leadership to support the rapid growth of the CGT market in the Asia Pacific Region.
APAC IC addresses challenges and bottlenecks impacting CGT development unique to the region, while promoting communication and alignment between Eastern and Western perspectives.
William Hwang
MBBS, MMed, FRCP, FAMS National Cancer Center,SingHealth, Singapore
Antonio S. J. Lee, BSc.(Hons), MSc., Ph.D
Medipost Co., Ltd.South Korea & USA
Heidi BergmanCell TherapiesAustralia Bingrong ChenThermo FisherSingapore Vorapin ChinchalongpornESPThailand Bryan ChoiEx Officio - ISCT Asia Regional CommitteeSouth Korea Lynn CsontosSTEMCELLCanada Alannah EvansKite PharmaAustralia/New Zealand Pawan GuptaAsia VP ElectIndia Juliana GutierrezBioMérieuxJapan William YK HwangAsia VPSingapore Shin KawamataAsia SecretaryJapan Srinivasan KellathurRegional AdvisorSingapore Kilian KellyCynataAustralia/New Zealand Wenyan LeongTerumo Blood and Cell TechnologiesJapan William MilliganSteminentCanada/Taiwan John NgDark Horse ConsultingSingapore Albeena NisarESPIndia Renee O'BrienNMDPUnited States
Steve OhIndependentSingapore Gabrielle O’SullivanRegional AdvisorAustralia/New Zealand Hadrien PianaLonzaBelgium Anit SinghGenophore ResearchIndia Kunihiko SuzukiAsia TreasurerJapan Eddie TanESPSingapore Yoshi TsurumakiFIRM (Forum for Innovative Regenerative Medicine)Japan Franziska UberPL BioScienceDenmark Zlatibor VelickovicEx OfficioAustralia Shane WinzarAustralian Red CrossAustralia Peter WooMiltenyi BiotecSouth Korea Bin WuAzentaChina Peiqing ZhangCytivaSingapore
View All Committees
